Related Experiment Video
Updated: May 6, 2026

Laparoscopic Technique for Serial Collection of Liver and Mesenteric Lymph Nodes in Macaques
Published on: May 2, 2017
Invasive Liver Abscess Syndrome in the Immunocompromised: A Case Report
Amey Joshi1, Eki Wari1, Harith Ghnaima1
1Department of Internal Medicine Sparrow Hospital-Michigan State University East Lansing Michigan USA.
Abstract:
Invasive liver abscess syndrome due to hypervirulent Klebsiella pneumoniae poses significant mortality risk, particularly in immunocompromised patients. Early recognition in non-endemic regions is crucial for prompt antibiotic therapy and source control, highlighting the need for increased suspicion and aggressive management of this rare disease to improve patient outcomes.
Insights
Hypervirulent Klebsiella pneumoniae can cause invasive liver abscess syndrome, a serious condition with high mortality, especially in immunocompromised individuals. Early diagnosis and aggressive treatment are vital for improving patient outcomes.
Area of Science:
- Infectious Diseases
- Hepatology
- Microbiology
Background:
- Invasive liver abscess syndrome is a severe condition caused by hypervirulent Klebsiella pneumoniae.
- This syndrome presents a significant mortality risk, particularly for immunocompromised patients.
- Early recognition in non-endemic regions is challenging but critical.
Purpose of the Study:
- To emphasize the importance of early recognition of invasive liver abscess syndrome due to hypervirulent Klebsiella pneumoniae in non-endemic areas.
- To highlight the need for prompt antibiotic therapy and source control.
- To advocate for increased clinical suspicion and aggressive management strategies.
Main Methods:
- Literature review on invasive liver abscess syndrome and hypervirulent Klebsiella pneumoniae.
- Analysis of clinical presentation and risk factors.
- Review of current treatment guidelines and outcomes.
Main Results:
- Hypervirulent Klebsiella pneumoniae is an emerging pathogen causing severe liver abscesses.
- Immunocompromised status is a key risk factor for poor outcomes.
- Delayed diagnosis correlates with increased morbidity and mortality.
Conclusions:
- Prompt diagnosis and aggressive management, including antibiotic therapy and source control, are essential for improving patient outcomes.
- Healthcare providers in non-endemic regions should maintain a high index of suspicion for this rare but dangerous infection.
- Further research into optimal treatment protocols for invasive liver abscess syndrome is warranted.
More Related Videos
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Hepatitis
Cirrhosis I: Introduction

